These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6099503)

  • 1. A monoclonal antibody directed against an opiate binding site in rat neural membranes.
    Bidlack JM; Denton RR
    Neuropeptides; 1984 Dec; 5(1-3):225-8. PubMed ID: 6099503
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding to mu and delta opioid sites but not kappa sites is inhibited by Fab fragments from a monoclonal antibody directed against the opioid receptor.
    Bidlack JM
    NIDA Res Monogr; 1986; 75():21-4. PubMed ID: 2828974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor.
    Bidlack JM; O'Malley WE; Schulz R
    Mol Pharmacol; 1988 Feb; 33(2):170-7. PubMed ID: 2828912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal anti-idiotypic antibody to mu and delta opioid receptors.
    Coscia CJ; Szücs M; Barg J; Belcheva MM; Bem WT; Khoobehi K; Donnigan TA; Juszczak R; McHale RJ; Hanley MR
    Brain Res Mol Brain Res; 1991 Mar; 9(4):299-306. PubMed ID: 1645433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of (+)[3H]SKF 10,047 binding to rat brain membranes by FAB fragments from a monoclonal antibody directed against the opioid receptor.
    Tyler CB; Bidlack JM
    Neurochem Res; 1988 Aug; 13(8):729-35. PubMed ID: 2845286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies against the S2-serotonin receptor from rat brain that cross-react with dopamine and opiate receptors.
    Deckmann M; Shinitzky M
    FEBS Lett; 1989 Jan; 243(2):371-6. PubMed ID: 2537236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating monoclonal antibodies to the opioid receptor.
    Bidlack JM; Denton RR; Harwell LW
    Life Sci; 1983; 33 Suppl 1():151-4. PubMed ID: 6319852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphiceptin: biphasic inhibition of mu-opiate receptor ligands.
    Villiger JW
    Pharmacol Biochem Behav; 1984 Nov; 21(5):705-6. PubMed ID: 6096895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyclonal anti-idiotypic opioid receptor antibodies generated by the monoclonal beta-endorphin antibody 3-E7.
    Schulz R; Gramsch C
    Biochem Biophys Res Commun; 1985 Oct; 132(2):658-65. PubMed ID: 2998376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed type inhibition of [D-Ala2, D-Leu5]enkephalin binding to mu-opiate binding sites by mu-, but not by kappa-opiate ligands.
    Pfeiffer A; Herz A
    Eur J Pharmacol; 1982 Feb; 77(4):359-61. PubMed ID: 6277680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabbit anti-idiotypic antibodies raised against monoclonal anti-morphine IgG block mu & delta opiate receptor sites.
    Glasel JA; Myers WE
    Life Sci; 1985 Jul; 36(26):2523-9. PubMed ID: 2989638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic morphine upregulates a mu-opiate binding site labeled by [3H]cycloFOXY: a novel opiate antagonist suitable for positron emission tomography.
    Rothman RB; McLean S; Bykov V; Lessor RA; Jacobson AE; Rice KC; Holaday JW
    Eur J Pharmacol; 1987 Oct; 142(1):73-81. PubMed ID: 2826178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a polyclonal antibody to the mu opioid receptor.
    Maneckjee R; Archer S; Zukin RS
    J Neuroimmunol; 1988 Feb; 17(3):199-208. PubMed ID: 2828423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody recognizing kappa- but not mu- and delta-opioid receptors.
    Maderspach K; Németh K; Simon J; Benyhe S; Szücs M; Wollemann M
    J Neurochem; 1991 Jun; 56(6):1897-904. PubMed ID: 1851205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antiidiotypic antibodies against delta opioid receptors as an electron microscopy probe.
    Cupo A; Conrath M; Eybalin M; Fourrier O; Zouaoui D; Kaldy P; Herbrecht F
    Eur J Cell Biol; 1992 Apr; 57(2):273-84. PubMed ID: 1324839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antiidiotypic antibodies which recognized the binding site of delta receptor: fine specificity of the antiidiotypic antibodies.
    Cupo A; Kaldy P
    NIDA Res Monogr; 1986; 75():25-8. PubMed ID: 2448627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural requirements for specific recognition of mu or delta opiate receptors.
    Fournie-Zaluski MC; Gacel G; Maigret B; Premilat S; Roques BP
    Mol Pharmacol; 1981 Nov; 20(3):484-91. PubMed ID: 6276710
    [No Abstract]   [Full Text] [Related]  

  • 18. Morphine-mimetic anti-paratypic antibodies: cross-reactive properties.
    Glasel JA; Pelosi LA
    Biochem Biophys Res Commun; 1986 May; 136(3):1177-84. PubMed ID: 3013170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential coupling of mu-competitive and mu-noncompetitive delta opiate receptors to guanine nucleotide binding proteins in rat brain membranes.
    Bowen WD; Rodrigues PA; Wanzor TE; Jacobson AE; Rice KC
    Biochem Pharmacol; 1988 Feb; 37(3):467-72. PubMed ID: 2827687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.